# Amphora Discovery Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amphora-discovery

- Industry: Biotechnology
- Headquarters: Durham, US
- Total disclosed funding: $72M
- Latest round: Series E (Feb 1, 2006)
- Investors on record: 9

## About

Founded in 2001, based in US, Amphora Discovery Corporation is a biotechnology company. Its services include screening and compound profiling services, custom assay development, enzymology services, and lead discovery/lead optimization partnering programs.

## Funding rounds

- Series E, Feb 1, 2006, $4M — 3i, ARCH Venture Partners, Versant Ventures, Southern Ute Indian Tribe Growth Fund, Novartis Venture Fund, Venrock, MPM BioImpact
- Series C, Dec 8, 2004, $20M — 3i, ARCH Venture Partners, Versant Ventures, Novartis Venture Fund, Venrock, MPM BioImpact, Aventis Capital
- Series B, Dec 17, 2002, $23M — ARCH Venture Partners, Versant Ventures, CW Group, Venrock, MPM BioImpact
- Series A, Oct 1, 2001, $25M — ARCH Venture Partners, Versant Ventures, CW Group, Venrock, MPM BioImpact

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B, Series C, Series E
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B, Series C, Series E
- CW Group (https://capitalatlas.ai/funds/cw-group) — Series A, Series B
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A, Series B, Series C, Series E
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A, Series B, Series C, Series E
- 3i (https://capitalatlas.ai/funds/3i) — Series C, Series E
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series C, Series E
- Aventis Capital — Series C
- Southern Ute Indian Tribe Growth Fund — Series E